FDA authorizes antiviral drug remdesivir as an outpatient therapy for people with covid-19 – The Washington Post

But along with the two new anti-covid pills, the broader use of remdesivir will “bolster the arsenal of therapeutics to treat covid-19 and respond to the surge of the omicron variant,” Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said. She added that the drug can be administered at “skilled nursing facilities, home health-care settings and outpatient facilities such as infusion centers.”